Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $14.9752W HIGH $38.44
Volume
79.56 K
Value Traded
31.65 M
Short % Float
9.1%
+2.4%Week
+8.89%1 Month
+14.5%3 Month
+93.52%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
1.41 B
EPS (TTM)
2.71
P/E Ratio
13.56
Ent. Value
1.06 B
Total Shares
38.72 M
Float Shares
38.35 M
Insiders
0.98%
Institutions
121.09%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
AMN Catalyst Timeline
Dated clinical, regulatory and corporate events for AMN Healthcare Services
Past FDA Catalysts and PDUFA Decisions
How AMN actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
AMN Healthcare Services is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AMN program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Laughlin Whitney MOfficer (Chief Legal Officer) | Option | 498 24,150 held | $0.00 | 09/15/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in AMN
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| Avidity Partners | 0.7 % | 34.27 M | 280.10 K |
AMN Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How AMN ranks across every disease it competes in
Competitive Position is a premium feature
See how AMN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialAMN News
-AMN
Oct 7, 2026▼ -0.8%today
AMN Healthcare to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026
AMN Healthcare Services, Inc. has announced a conference call to discuss its third quarter 2026 financial results and fourth quarter outlook. The call is scheduled for November 5, 2026, at 5:00 p.m. ET, with an earnings news release expected earlier that day. Participants can join via a live webcast or telephone.
Read more →-AMN
Aug 6, 2026▲ +16.9%on this news
AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS
AMN Healthcare Services, Inc. reported strong second quarter 2026 results with revenue of $673 million, a 2% increase from the prior year. Adjusted EBITDA rose by 26% to $73 million, driven by growth in travel nursing and allied solutions. However, revenue decreased significantly from the previous quarter, highlighting fluctuations in demand. The company also provided optimistic guidance for the third quarter, anticipating revenue growth.
Read more →-AMN
Jul 7, 2026AMN Healthcare to Hold Second Quarter 2026 Earnings Conference Call on Thursday, August 6, 2026
AMN Healthcare Services, Inc. has announced a conference call scheduled for August 6, 2026, to discuss its second quarter financial results and third quarter outlook. The call will be accessible via webcast and telephone, with a news release issued prior to the call. This event highlights the company's commitment to transparency and investor engagement.
Read more →-AMN
Apr 9, 2026AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
AMN Healthcare Services, Inc. has scheduled a conference call for May 7, 2026, to discuss its first quarter 2026 financial results and outlook for the second quarter. The call will be accessible via a live webcast and telephone registration. An earnings news release will precede the call, providing timely information to investors.
Read more →-AMN
Jan 23, 2026AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
AMN Healthcare has announced a conference call to discuss its fourth quarter and full year 2025 financial results, scheduled for February 19, 2026. The call will also provide insights into the company's outlook for the first quarter of 2026. A live webcast will be available, and a replay will be accessible afterward on the investor relations website.
Read more →-AMN
Nov 6, 2025▼ -10.7%on this news
AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2025 RESULTS
AMN Healthcare Services, Inc. has announced its third quarter 2025 financial results, highlighting quarterly revenue of $634 million and a notable net income of $29.3 million. Despite exceeding revenue guidance, the company experienced an 8% revenue drop compared to the previous year. The report indicates improved net income and operational efficiency, accentuated by successful debt refinancing efforts. However, certain segments reported declining revenues, raising concerns about ongoing market challenges.
Read more →-AMN
Sep 22, 2025AMN Healthcare Launches $400.0 Million Offering
AMN Healthcare Services has announced a private offering of $400 million in senior unsecured notes due 2031. Proceeds from this offering will primarily be used to redeem outstanding $500 million senior notes due 2027. The successful completion of this offering is crucial for the planned redemption, and it comes with certain market conditions. This move aims to enhance the company's capital structure and financial flexibility.
Read more →-AMN
Aug 7, 2025AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2025 RESULTS
AMN Healthcare reported its second-quarter 2025 results, revealing a revenue of $658 million and an adjusted EBITDA of $58.3 million. The company faced a GAAP loss of $116.2 million, influenced by substantial goodwill impairment charges. Despite challenges such as an 11% revenue decline year-over-year, segments like allied staffing exceeded projections, and strong operational cash flow facilitated debt reduction. The third-quarter outlook indicates further revenue decreases, raising concerns about ongoing market performance.
Read more →-AMN
May 8, 2025AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS
AMN Healthcare Services, Inc. has released its financial results for the first quarter of 2025, reporting a revenue of $690 million, a 16% decrease compared to the previous year. The company experienced a net loss of $1 million, resulting in a diluted loss per share of $0.03. Adjusted EPS was $0.45, indicating a decline from the $0.97 reported in Q1 2024. Despite challenges such as lower revenues in core staffing segments, the CEO remains optimistic about future market share gains and the impact of their tech-enabled solutions.
Read more →-AMN
Feb 20, 2025▲ +8.4%on this news
ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS
AMN Healthcare Services, Inc. announced its financial results for the fourth quarter and full year 2024, revealing a significant GAAP loss of $4.90 per share and a decrease in revenue by 21% year-over-year. The company reported challenges across its segments, particularly a notable decline in Nurse and Allied Solutions revenue. Despite some positive feedback regarding performance outpacing expectations, AMN's overall financial health reflects difficulties, including a substantial goodwill impairment. The outlook for the first quarter of 2025 indicates anticipated declines in revenue across multiple segments.
Read more →-AMN
Nov 7, 2024AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2024 RESULTS Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total tal
AMN Healthcare Services, Inc. announced its third quarter 2024 financial results, reporting a revenue of $688 million, a 19% decrease from the previous year. Despite challenges, the company exceeded revenue and earnings expectations, particularly in the Physician and Leadership Solutions segment, which saw a 13% revenue increase compared to last year. However, significant declines were noted in overall net income and in the Nurse and Allied Solutions segment. The outlook for the fourth quarter indicates continued revenue decreases from the previous year.
Read more →-AMN
Oct 3, 2024AMN Healthcare Appoints Brian Scott as CFO and COO Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for Mor
AMN Healthcare has appointed Brian Scott as both Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. Scott, who has over 17 years of experience with AMN, is expected to lead finance and operational functions as the company aims to enhance automation and scalability. His previous tenure saw considerable growth, including substantial revenue and EBITDA increases. Scott's appointment follows the departure of the current CFO, Jeffrey Knudson, who is transitioning to a role outside the healthcare industry.
Read more →-AMN
Oct 1, 2024AMN Healthcare Announces CFO Transition Jeffrey Knudson to Step Down as CFO Following Company's Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 O
AMN Healthcare Services announced the resignation of CFO Jeffrey Knudson, effective November 8, 2024, as he pursues an opportunity outside the healthcare staffing industry. The company plans to introduce a new leader for an expanded CFO/COO role prior to his departure. AMN also reaffirmed its outlook for the third quarter of 2024, indicating confidence in its financial guidance despite the leadership change. The transition of such a crucial role may pose challenges as the company seeks to maintain stability in its financial operations.
Read more →-AMN
Aug 8, 2024AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2024 RESULTS Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total ta
AMN Healthcare Inc. reported its second quarter 2024 results with a total revenue of $741 million, representing a 25% decrease from the previous year. While net income fell significantly to $16 million, the company noted improved performance in several areas, particularly in their VMS sales pipeline. Despite ongoing challenges, there are encouraging signs in the travel nurse market. The company provided a forecast for the third quarter, indicating further declines in revenue but growth in specific segments.
Read more →-AMN
May 9, 2024AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2024 RESULTS Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total tal
AMN Healthcare Services, Inc. reported its first-quarter 2024 results, highlighting a significant decrease in revenue to $821 million, a 27% drop from the previous year. Net income also fell to $17 million, reflecting the challenges in the nurse staffing segment, which saw a 44% decrease in travel nurse staffing revenue. Amidst these declines, AMN is proactively managing expenses and focusing on innovation to adapt to evolving healthcare market demands.
Read more →-AMN
Feb 15, 2024AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Quarterly revenue of $818 million; GAAP EPS of $0.33 and adjusted EPS of $1.32 DALLAS - (
AMN Healthcare Services, Inc. reported its fourth quarter and full year 2023 financial results, indicating a considerable decline in revenue and net income. During the quarter, the company generated $818 million in revenue, a 27% decrease from the previous year, with net income dropping to $12.5 million. Despite the decline, AMN is positioning itself for future growth through substantial investments in technology and the consolidation of its business operations under a unified brand. The outlook for Q1 2024 anticipates further declines in revenue across various segments, particularly in Nurse and Allied Solutions.
Read more →-AMN
Nov 2, 2023AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2023 RESULTS Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total tal
AMN Healthcare Services, Inc. reported its third quarter 2023 financial results, revealing a revenue decline of 25% year over year to $853.5 million and a net income drop of 42%. Despite these challenges, the company announced plans to acquire MSDR, signaling a strategic move to bolster its competitive position in the healthcare staffing market. Fourth quarter projections indicate that revenues are expected to decrease further by approximately 28-30% compared to the previous year. These results reflect ongoing challenges within the healthcare staffing industry.
Read more →-AMN
Oct 23, 2023Date: Monday
AMN Healthcare announced a definitive agreement to acquire MSDR for $300 million, enhancing its workforce solutions in healthcare staffing. This acquisition includes two specialist staffing companies, Medical Search International and DRW Healthcare Staffing, known for their expertise in locum tenens. The deal, expected to close in Q4 2023, is anticipated to generate significant revenue growth, with MSDR's revenue increasing from $104 million in 2022 to approximately $155 million year-to-date in 2023. AMN expects the acquisition to be accretive to adjusted EPS and beneficial for clients seeking a broader range of healthcare professionals.
Read more →-AMN
Aug 3, 2023▼ -5.5%on this news· ran to -17% by day 3
AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2023 RESULTS Quarterly revenue of $991 million; GAAP EPS of $1.55 and adjusted EPS of $2.38 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total ta
AMN Healthcare Services, Inc. announced its second quarter 2023 financial results, reporting a revenue of $991 million, which is a 31% decrease compared to the previous year. The company experienced a significant drop in net income, with a GAAP EPS of $1.55, down 44% year-over-year. Despite the challenges, AMN is focusing on technology investments to enhance their talent solutions and is aiming to adapt to changing client needs in healthcare staffing. The company's outlook for the third quarter indicates further expected revenue declines in various segments.
Read more →-AMN
May 4, 2023AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2023 RESULTS Quarterly revenue of $1.126 billion; GAAP EPS of $2.02 and adjusted EPS of $2.49 DALLAS - AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total t
AMN Healthcare reported its first quarter 2023 financial results, revealing a consolidated revenue of $1.126 billion, a decrease of 27% from the prior year. The company's net income and GAAP diluted EPS also saw significant declines of 42% and 35%, respectively. Despite these challenges, AMN remains optimistic about its future with investments in technology and leadership talent aimed at addressing the dynamic market needs. The company anticipates a continued decrease in revenue for the second quarter compared to the previous year.
Read more →About AMN Healthcare Services
Headquarters2999 OLYMPUS BOULEVARD, DALLAS, TX, 75019
BIOPHARMAWATCH ELITE PLUS
Trade the next AMN catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime